Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos
Tag Archives: dyslipidemia
Pharmacological management of nonalcoholic fatty liver disease: Limitations, challenges and new therapeutic opportunities
Eleni A. Karavia, Kyriakos E. Kypreos
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke
Eirini Konstantinidou, Konstantinos Tziomalos
The cardioprotective effects of flavonoids: a focus on classic cardiovascular risk factors
Eleni Kokkou, Nikoleta Bozini, Maria Lavda, Konstantinos Mourouzis, Gerasimos Siasos
Pathophysiological mechanisms of dyslipidemia in patients with nephrotic syndrome: A fresh look
M.S. Elisaf, S. Filippas-Ntekouan
Endothelial dysfunction in heart failure: The role of statins
Evangelos Oikonomou, Gerasimos Siasos, Christina Chrysohoou, Dimitris Tousoulis
Europe to US: Re-establish specific low density lipoprotein cholesterol targets because we all need them
Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis
The composite role of PCSK9 protein
E. Klouras, M. Elisaf
Effects of monotherapy with high-dose rosuvastatin compared with the combination of low-dose rosuvastatin with fenofibrate or n-3 fatty acids on non-lipid serum parameters in patients with severe mixed dyslipidemia
AP. Agouridis, TD. Filippatos, MS. Kostapanos, V. Tsimihodimos, DP. Mikhailidis, AD. Tselepis, MS. Elisaf
Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) A new approach to lipid lowering treatment
E. Klouras, E. Liberopoulos, M. Elisaf